Keyword Analysis & Research: syha136


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
syha1361.260.3467757

Keyword Research: People who searched syha136 also searched

Keyword CPC PCC Volume Score
syha1361.250.8182166
sha136241.160.3551950
(Choose at least 2 and not exceed 5 keywords)

Choose at least 2 and not exceed 5 keywords


Search Results related to syha136 on Search Engine

  • SYHA 136 - AdisInsight - Springer

    springer.com

    https://adisinsight.springer.com/drugs/800055489

    WEBDrug Profile. SYHA 136. Alternative Names: SYHA-136. Latest Information Update: 28 Dec 2022. Price : $50 * Buy Profile. Adis is an information provider. We do not sell or …

    DA: 19 PA: 8 MOZ Rank: 78

  • Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 …

    clinicaltrials.gov

    https://classic.clinicaltrials.gov/ct2/show/NCT04036656

    WEBJul 30, 2019 · Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers - Full Text View - ClinicalTrials.gov. Home. Search Results. … Allocation: Randomized Intervention Model: Parallel Assignment Estimated Enrollment : 56 participants Study Type : Interventional (Clinical Trial)

    Allocation: Randomized

    Intervention Model: Parallel Assignment

    Estimated Enrollment : 56 participants

    Study Type : Interventional (Clinical Trial)

    DA: 91 PA: 61 MOZ Rank: 78

  • Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 …

    veeva.com

    https://ctv.veeva.com/study/phase-i-study-of-direct-coagulation-factor-xa-inhibitor-syha136-tablets-in-chinese-healthy-volunteer

    WEBMar 21, 2024 · Phase 1. Conditions. Venous Thrombosis. Treatments. Drug: Placebo matching SYHA136 5 mg. Drug: Placebo matching SYHA136 2.5 mg. Drug: SYHA136 5 …

    DA: 45 PA: 36 MOZ Rank: 59

  • Home - ClinicalTrials.gov

    clinicaltrials.gov

    https://clinicaltrials.gov/ct2/show/NCT04036656

    WEBWe would like to show you a description here but the site won’t allow us.

    DA: 23 PA: 38 MOZ Rank: 80

  • Factor Xa Inhibitors: How They Work & Side Effects

    clevelandclinic.org

    https://my.clevelandclinic.org/health/treatments/24745-factor-xa-inhibitors

    OverviewProcedure DetailsRisks / BenefitsRecovery and OutlookWhen to Call the Doctor

    DA: 96 PA: 1 MOZ Rank: 43

  • Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 …

    trialbulletin.com

    https://trialbulletin.com/lib/entry/ct-04036656

    WEBJul 23, 2019 · Experimental: Cohort 5:SYHA136 10 mg or Placebo matching SYHA136 10 mg. Participants will receive a single oral dose of SYHA136 10 mg or Placebo matching …

    DA: 84 PA: 19 MOZ Rank: 45

  • SYHA136 0.5 mg and SYHA136 1 mg and SYHA136 2.5 mg in …

    ichgcp.net

    https://ichgcp.net/clinical-trials-registry/NCT04036656

    WEBJul 23, 2019 · Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers July 25, 2019 updated by: CSPC ZhongQi Pharmaceutical …

    DA: 20 PA: 73 MOZ Rank: 49

  • A pharmacokinetic study of SYHA136 in Beagle dogs

    magtechjournal.com

    http://journal18.magtechjournal.com/Jwk_zgyyyx/EN/10.13286/j.cnki.chinhosppharmacyj.2019.20.06

    WEBA pharmacokinetic study of SYHA136 in Beagle dogs: DING Shui-ping 1, ZHANG Ai-jie 2, ZHANG Rui-xing 3, QI Huan-huan 3, LIU Ya-jing 2, DAI Xiao-han 2: 1. Department of …

    DA: 31 PA: 97 MOZ Rank: 48

  • Single-center, Randomized, Double-blind, Placebo-controlled

    medifind.com

    https://www.medifind.com/articles/clinical-trial/4764524

    WEBWhen it comes to your health, nothing is more valuable than time. Quickly find the best doctors, latest medical advances, and active clinical trials with MediFind. Our goal is to …

    DA: 58 PA: 22 MOZ Rank: 40

  • History of Changes for Study: NCT04036656

    clinicaltrials.gov

    https://classic.clinicaltrials.gov/ct2/history/NCT04036656?V_1=View

    WEBPhase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers Official Title: Single-center, Randomized, Double-blind, Placebo …

    DA: 60 PA: 59 MOZ Rank: 46